Valeant raises offer for Allergan

Valeant Pharmaceuticals has raised its bid for Allergan, the company that makes Botox and other wrinkle smoothers. The Canadian drug maker is now offering $58.30 plus stock for each Allergan share. That could be worth more than $49 billion dollars. Shares of both companies were down in today’s session. Valeant by two percent and Allergan by more than five percent. Meg Tirrell is on the story for us.

This entry was posted in Biotech & Pharmaceuticals, M&A, NBR Show Clips. Bookmark the permalink.

Leave a Reply